R&D Navigating geopolitical risks: Practical and legal mitigatio... Geopolitical risk is now front of mind for many pharmaceutical leaders.
R&D Reliability in life sciences logistics: What good looks like What constitutes a reliable supply chain is changing rapidly.
R&D Cardiovascular disease today: NMR-based lipoprotein profilin... pharmaphorum spoke with Andreas Wolf, chief technology officer at numares Health about NMR-based lipoprotein profiling and cardiovascular disease.
R&D Changing Faces: Board of Director and Advisory Board hires, ... September’s boardroom moves brought seasoned pharma executives, investors, and scientific leaders into new governance and advisory roles across the life sciences sector.
R&D From reactive to predictive: How data is redefining pharma l... Pharmaceutical supply chains have more data at their fingertips than ever before. The challenge is turning that information into foresight.
R&D Removing barriers in treatment-resistant depression pharmaphorum speaks with Hans Eriksson, psychiatrist and CMO of FundaMental Pharma, about why treatment resistance remains such a challenge.
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
